Work

In reply to ‘Pre-screening with GeneXpert® MTB/RIF may increase use of isoniazid preventive therapy in antiretroviral programmes’ [Correspondence]

Year: 2011

Type: letter

Source: The International Journal of Tuberculosis and Lung Disease

DOI: 10.5588/ijtld.11.0407-2

Authors: Lukas Fenner, Andrew Boulle, Matthias Egger

Institutions: University of Bern, University of Cape Town

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Wellcome Trust

OpenAlex ID: W2330489409

Cites:

Cited by: 1

Related to: 10